Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method
File(s)20552076221128677.pdf (832.13 KB)
Published version
Author(s)
Type
Journal Article
Abstract
The prevalence of type 2 diabetes in North West London (NWL) is relatively high compared to other parts of the United Kingdom with outcomes suboptimal. This presents a need for more effective strategies to identify people living with type 2 diabetes who need additional support. An emerging subset of web-based interventions for diabetes self-management and population management have used artificial intelligence and machine learning models to stratify the risk of complications from diabetes and identify patients in need of immediate support. In this study, two prototype risk prediction tools on the MyWay Diabetes and MyWay Clinical platforms were evaluated with six clinicians and six people living with type 2 diabetes in North West London using the think aloud method. The results of the sessions with people living with type 2 diabetes showed that the concept of the tool was intuitive, however more instruction on how to correctly use the risk prediction tool would be valuable. The feedback from the sessions with clinicians was that the data presented in the tool aligned with the key diabetes targets in NWL, and that this would be particularly useful for identifying and inviting patients to the practice who are overdue for tests and at-risk of complications. The findings of the evaluation have been used to support the development of the prototype risk predictions tools. This study demonstrates the value of conducting usability and user experience testing on web-based interventions designed to support for supporting the targeted management of type 2 diabetes in local communities.
Date Issued
2023-01
Date Acceptance
2022-09-08
Citation
Digital Health, 2023, 9, pp.1-11
ISSN
2055-2076
Publisher
SAGE Publications
Start Page
1
End Page
11
Journal / Book Title
Digital Health
Volume
9
Copyright Statement
Creative Commons NonCommercial-NoDerivs CC BY-NC-ND: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Identifier
https://journals.sagepub.com/doi/10.1177/20552076221128677
Publication Status
Published
Date Publish Online
2023-01-08